Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Oligonucleotide
Revenue, means the sales value of Oligonucleotide
This report studies sales (consumption) of Oligonucleotide in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Abbott Molecular Inc. (US)
Life Technologies Corporation (US)
Affymetrix, Inc. (US)
PerkinElmer, Inc. (US)
Bluegnome, ltd. (UK)
Applied Spectral Imaging (US)
SciGene Corporation (US)
BI Biological Industries (Israel)
ChromTrax (US)
CytoTest, Inc. (UK)
Cytognomix, Inc. (Canada)
Illumina, Inc. (US)
Inter Medico (Canada)
Kreatech Diagnostics (The Netherlands)
Oxford Gene Technology (UK)
Roche NimbleGen, Inc. (US)
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Oligonucleotide in each application, can be divided into
Application 1
Application 2
Application 3
United States Oligonucleotide Market Report 2016
1 Oligonucleotide Overview
1.1 Product Overview and Scope of Oligonucleotide
1.2 Classification of Oligonucleotide
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Oligonucleotide
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Oligonucleotide (2011-2021)
1.4.1 United States Oligonucleotide Sales and Growth Rate (2011-2021)
1.4.2 United States Oligonucleotide Revenue and Growth Rate (2011-2021)
2 United States Oligonucleotide Competition by Manufacturers
2.1 United States Oligonucleotide Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Oligonucleotide Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Oligonucleotide Average Price by Manufactures (2015 and 2016)
2.4 Oligonucleotide Market Competitive Situation and Trends
2.4.1 Oligonucleotide Market Concentration Rate
2.4.2 Oligonucleotide Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Oligonucleotide Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Oligonucleotide Sales and Market Share by Type (2011-2016)
3.2 United States Oligonucleotide Revenue and Market Share by Type (2011-2016)
3.3 United States Oligonucleotide Price by Type (2011-2016)
3.4 United States Oligonucleotide Sales Growth Rate by Type (2011-2016)
4 United States Oligonucleotide Sales (Volume) by Application (2011-2016)
4.1 United States Oligonucleotide Sales and Market Share by Application (2011-2016)
4.2 United States Oligonucleotide Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Oligonucleotide Manufacturers Profiles/Analysis
5.1 Abbott Molecular Inc. (US)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Oligonucleotide Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Abbott Molecular Inc. (US) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Life Technologies Corporation (US)
5.2.2 Oligonucleotide Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Life Technologies Corporation (US) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Affymetrix, Inc. (US)
5.3.2 Oligonucleotide Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Affymetrix, Inc. (US) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 PerkinElmer, Inc. (US)
5.4.2 Oligonucleotide Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 PerkinElmer, Inc. (US) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Bluegnome, ltd. (UK)
5.5.2 Oligonucleotide Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Bluegnome, ltd. (UK) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Applied Spectral Imaging (US)
5.6.2 Oligonucleotide Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Applied Spectral Imaging (US) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 SciGene Corporation (US)
5.7.2 Oligonucleotide Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 SciGene Corporation (US) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 BI Biological Industries (Israel)
5.8.2 Oligonucleotide Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 BI Biological Industries (Israel) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 ChromTrax (US)
5.9.2 Oligonucleotide Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 ChromTrax (US) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 CytoTest, Inc. (UK)
5.10.2 Oligonucleotide Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 CytoTest, Inc. (UK) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Cytognomix, Inc. (Canada)
5.12 Illumina, Inc. (US)
5.13 Inter Medico (Canada)
5.14 Kreatech Diagnostics (The Netherlands)
5.15 Oxford Gene Technology (UK)
5.16 Roche NimbleGen, Inc. (US)
6 Oligonucleotide Manufacturing Cost Analysis
6.1 Oligonucleotide Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Oligonucleotide
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Oligonucleotide Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Oligonucleotide Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Oligonucleotide Market Forecast (2016-2021)
10.1 United States Oligonucleotide Sales, Revenue Forecast (2016-2021)
10.2 United States Oligonucleotide Sales Forecast by Type (2016-2021)
10.3 United States Oligonucleotide Sales Forecast by Application (2016-2021)
10.4 Oligonucleotide Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
Figure Picture of Oligonucleotide
Table Classification of Oligonucleotide
Figure United States Sales Market Share of Oligonucleotide by Type in 2015
Table Application of Oligonucleotide
Figure United States Sales Market Share of Oligonucleotide by Application in 2015
Figure United States Oligonucleotide Sales and Growth Rate (2011-2021)
Figure United States Oligonucleotide Revenue and Growth Rate (2011-2021)
Table United States Oligonucleotide Sales of Key Manufacturers (2015 and 2016)
Table United States Oligonucleotide Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Oligonucleotide Sales Share by Manufacturers
Figure 2016 Oligonucleotide Sales Share by Manufacturers
Table United States Oligonucleotide Revenue by Manufacturers (2015 and 2016)
Table United States Oligonucleotide Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Oligonucleotide Revenue Share by Manufacturers
Table 2016 United States Oligonucleotide Revenue Share by Manufacturers
Table United States Market Oligonucleotide Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Oligonucleotide Average Price of Key Manufacturers in 2015
Figure Oligonucleotide Market Share of Top 3 Manufacturers
Figure Oligonucleotide Market Share of Top 5 Manufacturers
Table United States Oligonucleotide Sales by Type (2011-2016)
Table United States Oligonucleotide Sales Share by Type (2011-2016)
Figure United States Oligonucleotide Sales Market Share by Type in 2015
Table United States Oligonucleotide Revenue and Market Share by Type (2011-2016)
Table United States Oligonucleotide Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Oligonucleotide by Type (2011-2016)
Table United States Oligonucleotide Price by Type (2011-2016)
Figure United States Oligonucleotide Sales Growth Rate by Type (2011-2016)
Table United States Oligonucleotide Sales by Application (2011-2016)
Table United States Oligonucleotide Sales Market Share by Application (2011-2016)
Figure United States Oligonucleotide Sales Market Share by Application in 2015
Table United States Oligonucleotide Sales Growth Rate by Application (2011-2016)
Figure United States Oligonucleotide Sales Growth Rate by Application (2011-2016)
Table Abbott Molecular Inc. (US) Basic Information List
Table Abbott Molecular Inc. (US) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Molecular Inc. (US) Oligonucleotide Sales Market Share (2011-2016)
Table Life Technologies Corporation (US) Basic Information List
Table Life Technologies Corporation (US) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Life Technologies Corporation (US) Oligonucleotide Sales Market Share (2011-2016)
Table Affymetrix, Inc. (US) Basic Information List
Table Affymetrix, Inc. (US) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Affymetrix, Inc. (US) Oligonucleotide Sales Market Share (2011-2016)
Table PerkinElmer, Inc. (US) Basic Information List
Table PerkinElmer, Inc. (US) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
Table PerkinElmer, Inc. (US) Oligonucleotide Sales Market Share (2011-2016)
Table Bluegnome, ltd. (UK) Basic Information List
Table Bluegnome, ltd. (UK) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bluegnome, ltd. (UK) Oligonucleotide Sales Market Share (2011-2016)
Table Applied Spectral Imaging (US) Basic Information List
Table Applied Spectral Imaging (US) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Applied Spectral Imaging (US) Oligonucleotide Sales Market Share (2011-2016)
Table SciGene Corporation (US) Basic Information List
Table SciGene Corporation (US) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
Table SciGene Corporation (US) Oligonucleotide Sales Market Share (2011-2016)
Table BI Biological Industries (Israel) Basic Information List
Table BI Biological Industries (Israel) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
Table BI Biological Industries (Israel) Oligonucleotide Sales Market Share (2011-2016)
Table ChromTrax (US) Basic Information List
Table ChromTrax (US) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
Table ChromTrax (US) Oligonucleotide Sales Market Share (2011-2016)
Table CytoTest, Inc. (UK) Basic Information List
Table CytoTest, Inc. (UK) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
Table CytoTest, Inc. (UK) Oligonucleotide Sales Market Share (2011-2016)
Table Cytognomix, Inc. (Canada) Basic Information List
Table Cytognomix, Inc. (Canada) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cytognomix, Inc. (Canada) Oligonucleotide Sales Market Share (2011-2016)
Table Illumina, Inc. (US) Basic Information List
Table Illumina, Inc. (US) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Illumina, Inc. (US) Oligonucleotide Sales Market Share (2011-2016)
Table Inter Medico (Canada) Basic Information List
Table Inter Medico (Canada) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Inter Medico (Canada) Oligonucleotide Sales Market Share (2011-2016)
Table Kreatech Diagnostics (The Netherlands) Basic Information List
Table Kreatech Diagnostics (The Netherlands) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kreatech Diagnostics (The Netherlands) Oligonucleotide Sales Market Share (2011-2016)
Table Oxford Gene Technology (UK) Basic Information List
Table Oxford Gene Technology (UK) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Oxford Gene Technology (UK) Oligonucleotide Sales Market Share (2011-2016)
Table Roche NimbleGen, Inc. (US) Basic Information List
Table Roche NimbleGen, Inc. (US) Oligonucleotide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche NimbleGen, Inc. (US) Oligonucleotide Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oligonucleotide
Figure Manufacturing Process Analysis of Oligonucleotide
Figure Oligonucleotide Industrial Chain Analysis
Table Raw Materials Sources of Oligonucleotide Major Manufacturers in 2015
Table Major Buyers of Oligonucleotide
Table Distributors/Traders List
Figure United States Oligonucleotide Production and Growth Rate Forecast (2016-2021)
Figure United States Oligonucleotide Revenue and Growth Rate Forecast (2016-2021)
Table United States Oligonucleotide Production Forecast by Type (2016-2021)
Table United States Oligonucleotide Consumption Forecast by Application (2016-2021)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...